250 related articles for article (PubMed ID: 20466178)
1. Rosaceiform dermatitis associated with topical tacrolimus treatment.
Fujiwara S; Okubo Y; Irisawa R; Tsuboi R
J Am Acad Dermatol; 2010 Jun; 62(6):1050-2. PubMed ID: 20466178
[TBL] [Abstract][Full Text] [Related]
2. Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream.
Gorman CR; White SW
Arch Dermatol; 2005 Sep; 141(9):1168. PubMed ID: 16172323
[No Abstract] [Full Text] [Related]
3. A rosacea-like granulomatous eruption in a patient using tacrolimus ointment for atopic dermatitis.
Bernard LA; Cunningham BB; Al-Suwaidan S; Friedlander SF; Eichenfield LF
Arch Dermatol; 2003 Feb; 139(2):229-31. PubMed ID: 12588240
[No Abstract] [Full Text] [Related]
4. Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment.
Antille C; Saurat JH; Lübbe J
Arch Dermatol; 2004 Apr; 140(4):457-60. PubMed ID: 15096374
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus-induced rosacea-like dermatitis: a clinical analysis of 16 cases associated with tacrolimus ointment application.
Teraki Y; Hitomi K; Sato Y; Izaki S
Dermatology; 2012; 224(4):309-14. PubMed ID: 22626964
[TBL] [Abstract][Full Text] [Related]
6. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
Chu CY
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
[TBL] [Abstract][Full Text] [Related]
7. Rosacea-like eruption due to topical pimecrolimus.
El-Heis S; Buckley DA
Dermatol Online J; 2015 May; 21(5):. PubMed ID: 26295863
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report.
Goldman D
J Am Acad Dermatol; 2001 Jun; 44(6):995-8. PubMed ID: 11369912
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus ointment for the treatment of severe facial plaque psoriasis.
Kroft EB; Erceg A; Maimets K; Vissers W; van der Valk PG; van de Kerkhof PC
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):249-51. PubMed ID: 15752305
[TBL] [Abstract][Full Text] [Related]
10. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
11. The use of topical tacrolimus and pimecrolimus to treat psoriasis: a review.
Scheinfeld N
Dermatol Online J; 2004 Jul; 10(1):3. PubMed ID: 15347485
[TBL] [Abstract][Full Text] [Related]
12. Rosaceiform dermatitis with follicular Demodex after treatment of facial atopic dermatitis with 1% pimecrolimus cream.
Lübbe J; Stucky L; Saurat JH
Dermatology; 2003; 207(2):204-5. PubMed ID: 12920379
[No Abstract] [Full Text] [Related]
13. Topical tacrolimus.
Frankel SJ; Kerdel FA
Skin Therapy Lett; 2001; 6(4):1-2, 5. PubMed ID: 11176043
[TBL] [Abstract][Full Text] [Related]
14. Topical tacrolimus and pimecrolimus: future directions.
Ling MR
Semin Cutan Med Surg; 2001 Dec; 20(4):268-74. PubMed ID: 11770914
[TBL] [Abstract][Full Text] [Related]
15. Molluscum contagiosum infection associated with pimecrolimus use in pityriasis alba.
Goksugur N; Ozbostanci B; Goksugur SB
Pediatr Dermatol; 2007; 24(5):E63-5. PubMed ID: 17958783
[TBL] [Abstract][Full Text] [Related]
16. The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
[TBL] [Abstract][Full Text] [Related]
17. Non-steroidal topical immunomodulators provide skin-selective, self-limiting treatment in atopic dermatitis.
Bos JD
Eur J Dermatol; 2003; 13(5):455-61. PubMed ID: 14693489
[TBL] [Abstract][Full Text] [Related]
18. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
[TBL] [Abstract][Full Text] [Related]
19. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
[TBL] [Abstract][Full Text] [Related]
20. Association between exposure to topical tacrolimus or pimecrolimus and cancers.
Hui RL; Lide W; Chan J; Schottinger J; Yoshinaga M; Millares M
Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
